Peer-influenced content. Sources you trust. No registration required. This is HCN.
UCSF MedConnection
Explore the potential of IS-002, an imaging agent that offers a new dimension in intraoperative prostate cancer detection, promising a more targeted approach to surgical intervention and patient management.
Oncology, Medical March 4th 2024
Johns Hopkins Medicine
In a significant advance for pediatric diabetes care, the introduction of the AI-based IDx-DR has doubled screening rates for diabetic retinopathy, underscoring the potential of technology to democratize healthcare access and eliminate racial bias in diagnostic processes.
Endocrinology, Diabetes, Metabolism February 26th 2024
Leveraging artificial intelligence, the CathEF algorithm offers a groundbreaking method to assess heart function directly from angiogram videos, potentially reducing the need for invasive diagnostics and enhancing patient care strategies.
Cardiology February 26th 2024
Johns Hopkins’ cardiac surgery team’s strategic expansion brings together globally recognized experts, enhancing our capabilities in treating complex heart conditions and advancing research in heart and lung transplantation.
Cardiology February 22nd 2024
Dana-Farber Cancer Institute
In the landmark KEYNOTE-564 trial, pembrolizumab has emerged as a pivotal advancement in kidney cancer treatment, offering hope by significantly prolonging survival in patients with high-risk ccRCC post-nephrectomy.
Oncology, Medical February 12th 2024
In recent research, elevated levels of a brain repair protein were found in former NFL athletes, suggesting ongoing inflammation and repair years after their careers. This highlights the need for continued monitoring and research into treatments for traumatic brain injuries.
Neurology February 6th 2024